Linked Hexokinase and Glucose-6-Phosphatase Activities Reflect Grade of Ovarian Malignancy

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Linked Hexokinase and Glucose-6-Phosphatase Activities Reflect Grade of Ovarian Malignancy. / Olsen, Birgitte Brinkmann; Gjedde, Albert; Vilstrup, Mie Holm; Johnsen, Iben Birgit Gade; Neumann, Gudrun; Torigian, Drew Avedis; Alavi, Abass; Høilund-Carlsen, Poul Flemming.

In: Molecular Imaging and Biology, Vol. 21, No. 2, 2019, p. 375-381.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Olsen, BB, Gjedde, A, Vilstrup, MH, Johnsen, IBG, Neumann, G, Torigian, DA, Alavi, A & Høilund-Carlsen, PF 2019, 'Linked Hexokinase and Glucose-6-Phosphatase Activities Reflect Grade of Ovarian Malignancy', Molecular Imaging and Biology, vol. 21, no. 2, pp. 375-381. https://doi.org/10.1007/s11307-018-1247-2

APA

Olsen, B. B., Gjedde, A., Vilstrup, M. H., Johnsen, I. B. G., Neumann, G., Torigian, D. A., Alavi, A., & Høilund-Carlsen, P. F. (2019). Linked Hexokinase and Glucose-6-Phosphatase Activities Reflect Grade of Ovarian Malignancy. Molecular Imaging and Biology, 21(2), 375-381. https://doi.org/10.1007/s11307-018-1247-2

Vancouver

Olsen BB, Gjedde A, Vilstrup MH, Johnsen IBG, Neumann G, Torigian DA et al. Linked Hexokinase and Glucose-6-Phosphatase Activities Reflect Grade of Ovarian Malignancy. Molecular Imaging and Biology. 2019;21(2):375-381. https://doi.org/10.1007/s11307-018-1247-2

Author

Olsen, Birgitte Brinkmann ; Gjedde, Albert ; Vilstrup, Mie Holm ; Johnsen, Iben Birgit Gade ; Neumann, Gudrun ; Torigian, Drew Avedis ; Alavi, Abass ; Høilund-Carlsen, Poul Flemming. / Linked Hexokinase and Glucose-6-Phosphatase Activities Reflect Grade of Ovarian Malignancy. In: Molecular Imaging and Biology. 2019 ; Vol. 21, No. 2. pp. 375-381.

Bibtex

@article{c8ab0c0c15c244ceb346903410c41687,
title = "Linked Hexokinase and Glucose-6-Phosphatase Activities Reflect Grade of Ovarian Malignancy",
abstract = "Purpose: Malignant cells exhibit increased rates of aerobic glycolysis. Here, we tested whether the accumulation of fluoro-deoxyglucose-6-phosphate (FDG6P) in ovarian cancers of differential malignancy reflects inversely correlated elevations of hexokinase (HK) and glucose-6-phosphatase (G6Pase) activities. Procedures: Twenty-nine women with suspected ovarian cancer had positron emission tomography (PET) prior to surgery. From fresh-frozen tissue, we determined the activities of HK and G6Pase, and from the PET images, we determined the tumor maximum standardized uptake value (SUVmax) of 2-deoxy-2-[18F]fluoro-D-glucose. Results: The SUVmax of malignant lesions significantly exceeded the SUVmax of benign (p < 0.005) and borderline lesions (p < 0.0005) that did not differ significantly. We found no significant correlation between measured HK or G6Pase activities and histological tumor type or SUVmax except that G6Pase activities were higher in malignant than borderline lesions (p < 0.05). Measured HK and G6Pase activities correlated inversely (p < 0.05). The slopes from the regression lines of the three correlations yielded positively correlated abscissa and ordinate intercepts, designated HKmax and G6Pasemax, respectively (r = 0.67, p < 0.0001). The positive correlations between the abscissa and ordinate intercepts with SUVmax had regression coefficients of r = 0.44, p < 0.05; and r = 0.39, p < 0.05, respectively. Conclusions: The results distinguished two ovarian cancer phenotypes, one with elevated HK activity and low G6Pase activity, and another with the opposite characteristics.",
keywords = "FDG, Glucose-6-phosphatase, Hexokinase, Ovarian cancer, Positron emission tomography (PET)",
author = "Olsen, {Birgitte Brinkmann} and Albert Gjedde and Vilstrup, {Mie Holm} and Johnsen, {Iben Birgit Gade} and Gudrun Neumann and Torigian, {Drew Avedis} and Abass Alavi and H{\o}ilund-Carlsen, {Poul Flemming}",
note = "Publisher Copyright: {\textcopyright} 2018, World Molecular Imaging Society.",
year = "2019",
doi = "10.1007/s11307-018-1247-2",
language = "English",
volume = "21",
pages = "375--381",
journal = "Molecular Imaging and Biology",
issn = "1536-1632",
publisher = "Springer",
number = "2",

}

RIS

TY - JOUR

T1 - Linked Hexokinase and Glucose-6-Phosphatase Activities Reflect Grade of Ovarian Malignancy

AU - Olsen, Birgitte Brinkmann

AU - Gjedde, Albert

AU - Vilstrup, Mie Holm

AU - Johnsen, Iben Birgit Gade

AU - Neumann, Gudrun

AU - Torigian, Drew Avedis

AU - Alavi, Abass

AU - Høilund-Carlsen, Poul Flemming

N1 - Publisher Copyright: © 2018, World Molecular Imaging Society.

PY - 2019

Y1 - 2019

N2 - Purpose: Malignant cells exhibit increased rates of aerobic glycolysis. Here, we tested whether the accumulation of fluoro-deoxyglucose-6-phosphate (FDG6P) in ovarian cancers of differential malignancy reflects inversely correlated elevations of hexokinase (HK) and glucose-6-phosphatase (G6Pase) activities. Procedures: Twenty-nine women with suspected ovarian cancer had positron emission tomography (PET) prior to surgery. From fresh-frozen tissue, we determined the activities of HK and G6Pase, and from the PET images, we determined the tumor maximum standardized uptake value (SUVmax) of 2-deoxy-2-[18F]fluoro-D-glucose. Results: The SUVmax of malignant lesions significantly exceeded the SUVmax of benign (p < 0.005) and borderline lesions (p < 0.0005) that did not differ significantly. We found no significant correlation between measured HK or G6Pase activities and histological tumor type or SUVmax except that G6Pase activities were higher in malignant than borderline lesions (p < 0.05). Measured HK and G6Pase activities correlated inversely (p < 0.05). The slopes from the regression lines of the three correlations yielded positively correlated abscissa and ordinate intercepts, designated HKmax and G6Pasemax, respectively (r = 0.67, p < 0.0001). The positive correlations between the abscissa and ordinate intercepts with SUVmax had regression coefficients of r = 0.44, p < 0.05; and r = 0.39, p < 0.05, respectively. Conclusions: The results distinguished two ovarian cancer phenotypes, one with elevated HK activity and low G6Pase activity, and another with the opposite characteristics.

AB - Purpose: Malignant cells exhibit increased rates of aerobic glycolysis. Here, we tested whether the accumulation of fluoro-deoxyglucose-6-phosphate (FDG6P) in ovarian cancers of differential malignancy reflects inversely correlated elevations of hexokinase (HK) and glucose-6-phosphatase (G6Pase) activities. Procedures: Twenty-nine women with suspected ovarian cancer had positron emission tomography (PET) prior to surgery. From fresh-frozen tissue, we determined the activities of HK and G6Pase, and from the PET images, we determined the tumor maximum standardized uptake value (SUVmax) of 2-deoxy-2-[18F]fluoro-D-glucose. Results: The SUVmax of malignant lesions significantly exceeded the SUVmax of benign (p < 0.005) and borderline lesions (p < 0.0005) that did not differ significantly. We found no significant correlation between measured HK or G6Pase activities and histological tumor type or SUVmax except that G6Pase activities were higher in malignant than borderline lesions (p < 0.05). Measured HK and G6Pase activities correlated inversely (p < 0.05). The slopes from the regression lines of the three correlations yielded positively correlated abscissa and ordinate intercepts, designated HKmax and G6Pasemax, respectively (r = 0.67, p < 0.0001). The positive correlations between the abscissa and ordinate intercepts with SUVmax had regression coefficients of r = 0.44, p < 0.05; and r = 0.39, p < 0.05, respectively. Conclusions: The results distinguished two ovarian cancer phenotypes, one with elevated HK activity and low G6Pase activity, and another with the opposite characteristics.

KW - FDG

KW - Glucose-6-phosphatase

KW - Hexokinase

KW - Ovarian cancer

KW - Positron emission tomography (PET)

U2 - 10.1007/s11307-018-1247-2

DO - 10.1007/s11307-018-1247-2

M3 - Journal article

C2 - 29987620

AN - SCOPUS:85049650272

VL - 21

SP - 375

EP - 381

JO - Molecular Imaging and Biology

JF - Molecular Imaging and Biology

SN - 1536-1632

IS - 2

ER -

ID: 286485629